Teva's divestment of its API division is in line with its st...

Teva's divestment of its API division is in line with its strategy to focus on branded medicines and slim down its generic medicine business. This move will enable Teva to concentrate its capital on driving the Pivot to Growth strategy, mainly around its innovative and generics portfolio.